Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world

In this study, patients with ES-SCLC who received immunotherapy were assigned to receive either TRT or no TRT. TRT significantly improved progression-free survival (PFS), local recurrence-free survival (LRFS) and OS with well tolerated toxicity. Further sub-cohort analysis, TRT significantly improved LRFS in patients with oligo-metastasis and without liver metastasis.
Source: Clinical and Experimental Metastasis - Category: Cancer & Oncology Source Type: research